Trial Profile
Absolute bioavailability trial of oral imatinib (Glivec) using a stable isotope labeled intravenous imatinib-d8 microdose
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 May 2020
Price :
$35
*
At a glance
- Drugs Imatinib (Primary) ; Imatinib (Primary)
- Indications Cancer; Gastrointestinal stromal tumours
- Focus Pharmacokinetics
- 19 May 2020 Results published in the European Journal of Clinical Pharmacology
- 19 May 2020 Status changed from not yet recruiting to completed as per results published in the European Journal of Clinical Pharmacology
- 14 Dec 2018 New trial record